Anthony Linton

1.6k total citations · 1 hit paper
32 papers, 1.2k citations indexed

About

Anthony Linton is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Anthony Linton has authored 32 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Pulmonary and Respiratory Medicine, 7 papers in Oncology and 3 papers in Surgery. Recurrent topics in Anthony Linton's work include Occupational and environmental lung diseases (24 papers), Pleural and Pulmonary Diseases (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers). Anthony Linton is often cited by papers focused on Occupational and environmental lung diseases (24 papers), Pleural and Pulmonary Diseases (12 papers) and Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (10 papers). Anthony Linton collaborates with scholars based in Australia, United States and New Zealand. Anthony Linton's co-authors include Nico van Zandwijk, Stephen Clarke, Glen Reid, Wendy A. Cooper, Steven Kao, Nick Pavlakis, Michael Boyer, Himanshu Brahmbhatt, Jennifer A. MacDiarmid and Scott Pattison and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Lancet Oncology.

In The Last Decade

Anthony Linton

30 papers receiving 1.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study

2017 539 citations Nico van Zandwijk, Nick Pavlakis et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anthony Linton Australia	15	606	528	482	211	108	32	1.2k
Xingxiang Pu China	17	570 0.9×	514 1.0×	253 0.5×	365 1.7×	85 0.8×	76	1.0k
Wen Liu China	15	407 0.7×	182 0.3×	210 0.4×	525 2.5×	94 0.9×	59	885
Joseph L. Sottnik United States	17	342 0.6×	163 0.3×	264 0.5×	341 1.6×	105 1.0×	26	837
Benjamin Tiede United States	6	596 1.0×	308 0.6×	143 0.3×	787 3.7×	130 1.2×	6	1.2k
Mitsuhito Kaji Japan	17	496 0.8×	177 0.3×	567 1.2×	318 1.5×	98 0.9×	53	1.3k
Laura Pazzaglia Italy	22	553 0.9×	404 0.8×	467 1.0×	296 1.4×	58 0.5×	51	1.1k
Mika Tanji United States	12	427 0.7×	178 0.3×	1.0k 2.1×	285 1.4×	120 1.1×	13	1.5k
Julius Klominek Sweden	21	254 0.4×	159 0.3×	289 0.6×	291 1.4×	136 1.3×	37	964
Randy Fagin United States	9	901 1.5×	798 1.5×	429 0.9×	332 1.6×	57 0.5×	11	1.5k
Zeyana Rivera United States	5	316 0.5×	101 0.2×	631 1.3×	240 1.1×	136 1.3×	7	1.0k

Countries citing papers authored by Anthony Linton

Since Specialization

Citations

This map shows the geographic impact of Anthony Linton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anthony Linton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anthony Linton more than expected).

Fields of papers citing papers by Anthony Linton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anthony Linton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anthony Linton. The network helps show where Anthony Linton may publish in the future.

Co-authorship network of co-authors of Anthony Linton

This figure shows the co-authorship network connecting the top 25 collaborators of Anthony Linton. A scholar is included among the top collaborators of Anthony Linton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anthony Linton. Anthony Linton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Linton, Anthony, et al.. (2025). Chrysotile asbestos—the deadly consequences of a retreat from national bans. The Lancet Respiratory Medicine. 13(10). 875–876.

Zhuang, Ling, Kenneth Lee, Sonja Klebe, et al.. (2025). A combination of PD-1 and TIGIT immune checkpoint inhibitors elicits a strong anti-tumour response in mesothelioma. Journal of Experimental & Clinical Cancer Research. 44(1). 51–51. 3 indexed citations

Bray, Victoria, Po Yee Yip, Anthony Linton, et al.. (2024). Real world efficacy and toxicity of consolidation durvalumab following chemoradiotherapy in older Australian patients with unresectable stage III non-small cell lung cancer. Journal of Geriatric Oncology. 15(2). 101705–101705. 7 indexed citations

Linton, Anthony, Steven Kao, Sonja Klebe, et al.. (2023). High mesothelin expression by immunohistochemistry predicts improved survival in pleural mesothelioma. Histopathology. 83(2). 202–210. 8 indexed citations

Linton, Anthony, et al.. (2020). The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer. SHILAP Revista de lepidopterología. 11 indexed citations

Cheng, Yuen Yee, Emma M. Rath, Ling Zhuang, et al.. (2020). CDKN2A and MTAP Are Useful Biomarkers Detectable by Droplet Digital PCR in Malignant Pleural Mesothelioma: A Potential Alternative Method in Diagnosis Compared to Fluorescence In Situ Hybridisation. Frontiers in Oncology. 10. 579327–579327. 14 indexed citations

Cheng, Yuen Yee, et al.. (2020). <p>The Current Understanding Of Asbestos-Induced Epigenetic Changes Associated With Lung Cancer</p>. PubMed. Volume 11. 1–11. 21 indexed citations

Ahmadzada, Tamkin, Kenneth Lee, Candice Clarke, et al.. (2019). High BIN1 expression has a favorable prognosis in malignant pleural mesothelioma and is associated with tumor infiltrating lymphocytes. Lung Cancer. 130. 35–41. 17 indexed citations

Linton, Anthony, et al.. (2019). Patterns of care and survival of older patients with malignant pleural mesothelioma. Journal of Geriatric Oncology. 10(4). 573–576. 3 indexed citations

10.

Linton, Anthony, Matthew Soeberg, Steven Kao, Richard Broome, & Nico van Zandwijk. (2017). P3.03-033 The Influence of Geographic and Socioeconomic Factors on Prognosis and Treatment Provision in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 12(1). S1364–S1365. 1 indexed citations

11.

Kao, Steven, Yuen Yee Cheng, Marissa Williams, et al.. (2017). Tumor Suppressor microRNAs Contribute to the Regulation of PD-L1 Expression in Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 12(9). 1421–1433. 119 indexed citations

12.

Zandwijk, Nico van, Nick Pavlakis, Steven Kao, et al.. (2017). Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study. The Lancet Oncology. 18(10). 1386–1396. 539 indexed citations breakdown →

13.

Johnson, Thomas G., Karin Schelch, Yuen Yee Cheng, et al.. (2017). Dysregulated Expression of the MicroRNA miR-137 and Its Target YBX1 Contribute to the Invasive Characteristics of Malignant Pleural Mesothelioma. Journal of Thoracic Oncology. 13(2). 258–272. 43 indexed citations

14.

Linton, Anthony, Matthew Soeberg, Richard Broome, Steven Kao, & Nico van Zandwijk. (2017). Geographic and socioeconomic factors in patients with malignant pleural mesothelioma in New South Wales and their impact upon clinical outcomes. Respirology. 22(5). 978–985. 6 indexed citations

15.

Williams, Marissa, Michaela B. Kirschner, Yuen Yee Cheng, et al.. (2015). miR-193a-3p is a potential tumor suppressor in malignant pleural mesothelioma. Oncotarget. 6(27). 23480–23495. 64 indexed citations

16.

Kirschner, Michaela B., Yuen Yee Cheng, Nicola J. Armstrong, et al.. (2014). MiR‐Score: A novel 6‐microRNA signature that predicts survival outcomes in patients with malignant pleural mesothelioma. Molecular Oncology. 9(3). 715–726. 56 indexed citations

17.

Linton, Anthony, Yuen Yee Cheng, Kim Griggs, et al.. (2013). An RNAi-based screen reveals PLK1, CDK1 and NDC80 as potential therapeutic targets in malignant pleural mesothelioma. British Journal of Cancer. 110(2). 510–519. 40 indexed citations

18.

Linton, Anthony, Gregory R. Pond, Stephen Clarke, et al.. (2013). Glasgow Prognostic Score As a Prognostic Factor in Metastatic Castration-Resistant Prostate Cancer Treated With Docetaxel-Based Chemotherapy. Clinical Genitourinary Cancer. 11(4). 423–430. 36 indexed citations

19.

Linton, Anthony, Steven Kao, Janette L. Vardy, et al.. (2012). Immunohistochemistry in the diagnosis of malignant pleural mesothelioma: Trends in Australia and a literature review. Asia-Pacific Journal of Clinical Oncology. 9(3). 273–279. 10 indexed citations

20.

Linton, Anthony, Janette L. Vardy, Stephen Clarke, & Nico van Zandwijk. (2012). The ticking time-bomb of asbestos: Its insidious role in the development of malignant mesothelioma. Critical Reviews in Oncology/Hematology. 84(2). 200–212. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact